Status:
COMPLETED
A Study of Flt3-Ligand Levels in Sjögrens Syndrome
Lead Sponsor:
Göteborg University
Conditions:
Sjogrens Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Detailed Description
The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Eligibility Criteria
Inclusion
- fulfill the ACR-criteria for primary Sjogrens syndrome,
- age above 18 years old
Exclusion
- other CNS-disease
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01470638
Start Date
June 1 2009
End Date
April 1 2019
Last Update
April 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Rheumatology, Sahlgrenska University Hospital
Gothenburg, Sweden, 413 46